(1S)-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3-(oxan-4-ylamino)cyclopentane-1-carboxamide
C20H24F6N2O2 — CID 142976792
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1S)-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3-(oxan-4-ylamino)cyclopentane-1-carboxamide
(1S)-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3-(oxan-4-ylamino)cyclopentane-1-carboxamide (PubChem CID 142976792) has the molecular formula C20H24F6N2O2 and a molecular weight of 438.41 g/mol. Its IUPAC name is (1S)-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3-(oxan-4-ylamino)cyclopentane-1-carboxamide.
Molecular Properties
| Compound Name | (1S)-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3-(oxan-4-ylamino)cyclopentane-1-carboxamide |
|---|---|
| PubChem CID | 142976792 |
| Molecular Formula | C20H24F6N2O2 |
| Molecular Weight | 438.41 g/mol |
| Exact Mass | 438.17 |
| IUPAC Name | (1S)-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3-(oxan-4-ylamino)cyclopentane-1-carboxamide |
| SMILES | O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@H]1CCC(NC2CCOCC2)C1 |
| InChI | InChI=1S/C20H24F6N2O2/c21-19(22,23)14-7-12(8-15(10-14)20(24,25)26)11-27-18(29)13-1-2-17(9-13)28-16-3-5-30-6-4-16/h7-8,10,13,16-17,28H,1-6,9,11H2,(H,27,29)/t13-,17?/m0/s1 |
| InChIKey | WPJKXNZNCDJMLI-CWQZNGJJSA-N |
| XLogP | 4.28 |
| TPSA | 50.36 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.41 |
| LogP ≤ 5 | 4.28 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142976792 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.